97 related articles for article (PubMed ID: 18604982)
1. C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies.
Dass CR; Choong PF
Pharmazie; 2008 Jun; 63(6):411-4. PubMed ID: 18604982
[TBL] [Abstract][Full Text] [Related]
2. Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity.
Dass CR; Friedhuber AM; Khachigian LM; Dunstan DE; Choong PF
J Microencapsul; 2008 Sep; 25(6):421-5. PubMed ID: 18465314
[TBL] [Abstract][Full Text] [Related]
3. Specific repression of mutant K-RAS by 10-23 DNAzyme: sensitizing cancer cell to anti-cancer therapies.
Yu SH; Wang TH; Au LC
Biochem Biophys Res Commun; 2009 Jan; 378(2):230-4. PubMed ID: 19014906
[TBL] [Abstract][Full Text] [Related]
4. Dz13: c-Jun downregulation and tumour cell death.
Elahy M; Dass CR
Chem Biol Drug Des; 2011 Dec; 78(6):909-12. PubMed ID: 21722318
[TBL] [Abstract][Full Text] [Related]
5. Two DNAzymes targeting the telomerase mRNA with large difference in Mg2+ concentration for maximal catalytic activity.
Yuan BF; Xue Y; Luo M; Hao YH; Tan Z
Int J Biochem Cell Biol; 2007; 39(6):1119-29. PubMed ID: 17499543
[TBL] [Abstract][Full Text] [Related]
6. Delivery of a DNAzyme targeting c-myc to HT29 colon carcinoma cells using a gold nanoparticulate approach.
Tack F; Noppe M; Van Dijck A; Dekeyzer N; Van Der Leede BJ; Bakker A; Wouters W; Janicot M; Brewster ME
Pharmazie; 2008 Mar; 63(3):221-5. PubMed ID: 18444511
[TBL] [Abstract][Full Text] [Related]
7. DNAzymes as potential therapeutic molecules.
Isaka Y
Curr Opin Mol Ther; 2007 Apr; 9(2):132-6. PubMed ID: 17458166
[TBL] [Abstract][Full Text] [Related]
8. DNAzyme targeting c-jun suppresses skin cancer growth.
Cai H; Santiago FS; Prado-Lourenco L; Wang B; Patrikakis M; Davenport MP; Maghzal GJ; Stocker R; Parish CR; Chong BH; Lieschke GJ; Wong TW; Chesterman CN; Francis DJ; Moloney FJ; Barnetson RS; Halliday GM; Khachigian LM
Sci Transl Med; 2012 Jun; 4(139):139ra82. PubMed ID: 22723462
[TBL] [Abstract][Full Text] [Related]
9. Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets.
Vester B; Hansen LH; Lundberg LB; Babu BR; Sørensen MD; Wengel J; Douthwaite S
BMC Mol Biol; 2006 Jun; 7():19. PubMed ID: 16753066
[TBL] [Abstract][Full Text] [Related]
10. DNAzymes and their therapeutic possibilities.
Chan CW; Khachigian LM
Intern Med J; 2009 Apr; 39(4):249-51. PubMed ID: 19402864
[TBL] [Abstract][Full Text] [Related]
11. The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity.
Rivory L; Tucker C; King A; Lai A; Goodchild A; Witherington C; Gozar MM; Birkett DJ
Oligonucleotides; 2006; 16(4):297-312. PubMed ID: 17155906
[TBL] [Abstract][Full Text] [Related]
12. DNAzymes: cutting a path to a new class of therapeutics.
Khachigian LM
Curr Opin Mol Ther; 2002 Apr; 4(2):119-21. PubMed ID: 12044032
[TBL] [Abstract][Full Text] [Related]
13. Electrochemical DNAzyme sensor for lead based on amplification of DNA-Au bio-bar codes.
Shen L; Chen Z; Li Y; He S; Xie S; Xu X; Liang Z; Meng X; Li Q; Zhu Z; Li M; Le XC; Shao Y
Anal Chem; 2008 Aug; 80(16):6323-8. PubMed ID: 18627134
[TBL] [Abstract][Full Text] [Related]
14. DNAzymes to mouse beta1 integrin mRNA in vivo: targeting the tumor vasculature and retarding cancer growth.
Niewiarowska J; Sacewicz I; Wiktorska M; Wysocki T; Stasikowska O; Wagrowska-Danilewicz M; Cierniewski CS
Cancer Gene Ther; 2009 Sep; 16(9):713-22. PubMed ID: 19247396
[TBL] [Abstract][Full Text] [Related]
15. Cancer, chitosan nanoparticles and catalytic nucleic acids.
Tan ML; Choong PF; Dass CR
J Pharm Pharmacol; 2009 Jan; 61(1):3-12. PubMed ID: 19126291
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of a uranyl ion-specific DNAzyme.
Brown AK; Liu J; He Y; Lu Y
Chembiochem; 2009 Feb; 10(3):486-92. PubMed ID: 19142882
[TBL] [Abstract][Full Text] [Related]
17. Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function.
Khachigian LM; Cai H; Moloney FJ; Parish CR; Chong BH; Stocker R; Barnetson RS; Halliday GM
Oncotarget; 2012 Jun; 3(6):594-5. PubMed ID: 22805148
[TBL] [Abstract][Full Text] [Related]
18. Cooperative multicomponent self-assembly of nucleic acid structures for the activation of DNAzyme cascades: a paradigm for DNA sensors and aptasensors.
Elbaz J; Moshe M; Shlyahovsky B; Willner I
Chemistry; 2009; 15(14):3411-8. PubMed ID: 19206117
[TBL] [Abstract][Full Text] [Related]
19. Preclinical anticancer activity of DNA-based cleavage molecules.
Dass CR
Drug Dev Ind Pharm; 2006 Jan; 32(1):1-5. PubMed ID: 16455599
[TBL] [Abstract][Full Text] [Related]
20. Tetrahedral DNA Nanostructure-Delivered DNAzyme for Gene Silencing to Suppress Cell Growth.
Meng L; Ma W; Lin S; Shi S; Li Y; Lin Y
ACS Appl Mater Interfaces; 2019 Feb; 11(7):6850-6857. PubMed ID: 30698411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
